Predictors of end stage lung disease in systemic sclerosis

Ann Rheum Dis. 2003 Feb;62(2):97-9. doi: 10.1136/ard.62.2.97.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Antinuclear / analysis
  • Biomarkers / analysis
  • Humans
  • Hypertension, Pulmonary / etiology*
  • Pulmonary Fibrosis / etiology*
  • Scleroderma, Systemic / complications*
  • Vital Capacity

Substances

  • Antibodies, Antinuclear
  • Biomarkers